Arthritis Drug Cuts GVHD Risk in Stem Cell Transplants January 27, 2021 · by Aviatior · in Biotechnology industry, iPS Cells, Personalized Therapies, Regenerative Medicine. · https://www.medpagetoday.com/hematologyoncology/leukemia/90885 Share this:Share on TumblrTweetWhatsAppTelegramEmailPrintMorePocketLike this:Like Loading... Related